New Nature Study Uses Mission Bio's Tapestri Platform for Single-nuclei Sequencing of Solid Tissue

Retrieved on: 2021-05-18 13:52:30

Tags for this article:

Click the tags to see associated articles and topics

New Nature Study Uses Mission Bio's Tapestri Platform for Single-nuclei Sequencing of Solid Tissue. View article details on hiswai:

Excerpt

Founded in 2014, Mission Bio has secured investment from Novo Growth, Cota Capital, Agilent Technologies, Mayfield Fund, and others.

Article found on: www.prnewswire.com